SCHEDULE 13G/A

OCULIS HOLDING AG

Ordinary Shares, CHF 0.01 par value per share · CUSIP: H5870P102

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Nan Fung Group Holdings Limited

  Shares: 2,815,476 · Class: 4.9%

• NF Investment Holdings Limited

  Shares: 2,815,476 · Class: 4.9%

• Nan Fung Life Sciences Holdings Limited

  Shares: 2,815,476 · Class: 4.9%

• NFLS Platform Holdings Limited

  Shares: 514,702 · Class: 0.9%

• NFLS Beta Limited

  Shares: 514,702 · Class: 0.9%

• Pivotal Life Sciences Holdings Limited

  Shares: 2,300,774 · Class: 4.0%

• Pivotal Partners Ltd

  Shares: 2,300,774 · Class: 4.0%

• Pivotal bioVenture Partners Fund I U.G.P. Ltd.

  Shares: 2,300,774 · Class: 4.0%

• Pivotal bioVenture Partners Fund I G.P., L.P.

  Shares: 2,300,774 · Class: 4.0%

• Pivotal bioVenture Partners Fund I, L.P.

  Shares: 2,300,774 · Class: 4.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.